A pill that doubles life expectancy in patients with pancreatic cancer has been hailed as the biggest breakthrough for decades. Doctors are billing daraxonrasib as a “revolution” in cancer treatment, ...

Scientists at the world's largest cancer conference have hailed the start of a new drug 'revolution'.

A daily pill doubled patients’ survival in metastatic pancreatic cancer treatment by blocking one of the primary drivers of ...

Pancreatic cancer advocates in New Mexico say a new treatment could be a major breakthrough for people with the disease and ...

"The fight is on,” a Port St. Lucie man said when diagnosed with pancreatic cancer. He didn't expect to fight the drug ...

Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough.

The eagerly awaited full dataset from the most pivotal pancreatic cancer study in decades didn’t just live up to expectations ...